Clinical Trial Update: Teclistamab in Newly Diagnosed Mayo Stage IIIB AL Amyloidosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating teclistamab in newly diagnosed Mayo Stage IIIB AL amyloidosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis

Drugs mentioned

• TECVAYLI (TECLISTAMAB-CQYV)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: AL Amyloidosis | Phase 2 | Status: RECRUITING